Prot# A4091018: A Phase 3 Randomized, Double-Blind, Placebo and Naproxen Controlled Multicenter Study of the Analgesic Efficacy and Safety of Tanezumab in Patients with Osteoarthritis of the Hip

Project: Research project

Project Details

StatusFinished
Effective start/end date7/9/09 → 7/9/12

Funding

  • INC Research, LLC (A4091018)
  • Pfizer Inc. (A4091018)